Developmental therapeutics: review of biologically based complementary and alternative medicine (CAM) therapies for potential application in children with cancer-part II.

S. Melnick
DOI: https://doi.org/10.1097/01.MPH.0000212900.76523.16
2006-05-01
Journal of Pediatric Hematology/Oncology
Abstract:This is part two of a review of the status of biologically based complementary and alternative medicine (CAM) therapies that have potential anticancer activity, with a focus on those agents that may be active in childhood cancer. The review, presented in two parts, includes descriptions of the mechanisms that underlie their effects, the manner by which these agents are identified and evaluated, and discussion of some of the limitations of current research. The first part 1–81 introduced the topic of biologically based CAM therapies. The discussion included a description of the discovery of biologically based products for cancer, the classification of these compounds, and their use, from the perspectives of the Ayurvedic and traditional Chinese medicine (TCM) systems. Issues associated with evidence-based research of compounds used in these practices are addressed. This part focuses on preclinical and clinical studies of specific herbs or natural products and their bioactive constituents that demonstrate potential in cancer therapeutics. Turmeric, mistletoe, green tea, ginseng, mushrooms, and micronutrients are representative of compounds that exert their effects through mechanisms attributed to specific chemical classes. The section concludes with a discussion of the status of clinical trials of biologically based CAM therapeutics for cancer and the future direction of research.
What problem does this paper attempt to address?